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In this issue ofDevelopmental Cell, Takada et al. (2006)
describe a novel lipid modification in Wnt3a. This
exciting finding may prove pivotal in our attempts to
decipher the mechanisms underlying Wnt secretion.
The biological readout of the Wnt signal is diverse, con-
trolling processes such as cell proliferation, migration,
and differentiation. Wnt signaling plays a role in body
axis specification and is also important for stem cell
maintenance. Aberrant Wnt signaling is implicated in
developmental disorders, degenerative diseases, and
cancer (Logan and Nusse, 2004).
The production and movement of Wnts is tightly con-
trolled. Normally they are distributed in a graded fashion
throughout tissues adjacent to where they are pro-
duced. Hence the Wnt pathway is activated to different
degrees leading to subtle but crucial differences in the
repertoire and level of target gene expression. This
property defines Wnts as morphogens, acting as both
short- and long-range signaling molecules. Over the
last two decades we have gained enormous insights
into the steps in the signaling cascade initiated in the
receiving cell (Logan and Nusse, 2004). However, the
events in the producing cell and the processes control-
ling the movement of the Wnt proteins to generate the
signaling gradient remain to be elucidated.
One perplexing property of Wnts, not predicted from
their primary sequence, is that they are highly hydro-
phobic. In 2003, Willert et al. showed that Wnt proteins
are palmitoylated on a conserved cysteine residue (cys-
teine 77 in murine Wnt3a), thereby apparently solving
the mystery of Wnt hydrophobicity (Willert et al.,
2003). However, some discrepancies remained includ-
ing the observation that the effect of mutating this cys-
teine to alanine did not completely recapitulate the con-
sequences of loss of Porcupine, the O-acyl-transferase
believed to modify Wnt proteins. In this issue of Devel-
opmental Cell, Takada et al. (2006) report that murine
Wnt3a has a second unusual acyl modification at a
conserved serine residue (S209) and that this acylation
requires Porcupine. The modification is a monounsatu-
rated fatty acid, palmitoleic acid (Figure 1).
There are several classes of protein acylation in eu-
karyotic cells: N-myristoylation, N-palmitoylation, S-
palmitoylation, and O-acylation (Smotrys and Linder,
2004). Whereas the biology and enzymology of protein
N-myristoylation have been extensively characterized,
the other modes of protein acylation are less well under-
stood. N-palmitoylated proteins have a palmitate group
covalently bound via amide linkage. It was first de-
scribed for sonic hedgehog, another morphogen, where
the N-terminal cysteine residue of Hedgehog is modi-
fied with amide-linked palmitate. S-palmitoylation is
the reversible addition of palmitate or other long chain
fatty acids to proteins at cysteine residues via a thio-ester linkage. Fatty acid acylation also occurs through
oxyester linkage to serine or threonine residues (O-acyl-
ation). Thioester-linked and oxyester-linked acyl moie-
ties are differentially labile with the oxyester linkage
being more stable under certain experimental condi-
tions, such as high concentrations of disulfide-reducing
agents (2-mercaptoethanol or dithiothreitol). Under
such reducing conditions, Takada and colleagues ob-
served a form of palmitic acid (U-14C) labeled Wnt3a
protein, suggesting to them the existence of an addi-
tional, presumably oxyester-linked, palmitoylation. The
novel Wnt modification described by Takada et al. is
the newest example of this type of ‘‘O-acylation.’’
Protein palmitoylation exerts diverse effects; the con-
sequences of which depend on the nature of the modi-
fied protein (Smotrys and Linder, 2004). The obvious out-
come is that it increases the hydrophobicity of proteins
or protein domains and modulates their membrane asso-
ciation. Palmitoylation also influences intracellular pro-
tein trafficking and targeting. One pertinent example is
that palmitoylation regulates protein targeting to lipid mi-
crodomains in the plasma membrane, such as lipid rafts.
It may also regulate earlier steps in the secretory path-
way. Indeed, this might be the role of the acylation of
S209 in Wnt3a, as Takada et al. (2006) found that mutat-
ing S209 to alanine results in retention of Wnt3a protein in
the cell. They used cycloheximide to block de novo pro-
tein synthesis (Wnt3a production) and then examined the
retention of different forms of Wnts. The S209A form of
Wnt3a was being retained in the ER. In the cell line they
used, transfected Wnt3a was present predominantly in
the ER revealing that the transport from the ER to the
Golgi was a rate limiting step, even for the wild-type pro-
tein, and that this step is further impeded by the loss of
S209 acylation. It is important to note however that, while
it is appealing to consider that the acylation at S209 is
required for the movement from the ER, an alternative
explanation for the results is that mutating S209 simply
produces a misfolded protein that is retained in the ER.
The retention is reminiscent of that seen following the
loss of the gene porc, where earlier reports had sug-
gested that Porc is required for Wnt protein secretion
(Kadowaki et al., 1996). Using RNAi, Takada et al. (2006)
were able to show that porc is required for secretion
and further that it is required for S209-dependent acyla-
tion of Wnt3a from cultured cells. Interestingly the glyco-
sylation of a S209A mutant Wnt protein is apparently nor-
mal, whereas loss of Porc activity appears to influence
the glycosylation status of Wnts. In the absence of addi-
tional data, the reasons for this difference remain unclear.
A surprising twist came when mass spectrometry
analysis of purified secreted Wnt3a revealed that the
peptide containing S209 was modified with a monoun-
saturated fatty acid: palmitoleic acid (C16:1) (Figure 1).
This is an unusual fatty acid modification. The functional
significance of acylation with an unsaturated fatty acid
remains to be elucidated. The authors do propose that
the bent structure of the unsaturated fatty acid might
be advantageous for packaging fatty acid chains into
the interior of small lipid particles. This would fit nicely
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752Figure 1. A Schematic Overview of the Posi-
tion and Nature of the Posttranslational Mod-
ifications Found in Murine Wnt3a
The structures of the palmitate attached at
cysteine 77 (C77) and the newly identified pal-
mitoleic acid attached at serine 209 (S209)
are shown (not to scale). For the two possible
N-glycosylation sites at asparagines 87 and
298 (N87 and N298), the structure of the gly-
cosyl side chain is not known.with a recent proposition that lipoprotein particles serve
as extracellular transporters of Wnts (Panakova et al.,
2005). Both in vivo and in vitro results indicate that un-
saturated fatty acylation results in displacement of pro-
teins, including Fyn and Gai, from membrane domains
within ordered lipid structures (Liang et al., 2001). Tak-
ing this into account, an alternative hypothesis is that
the unsaturated fatty acid acylation is generated by a
desaturase—modifying a saturated precursor that was
originally attached to the protein. Altering the properties
of the fatty acid chain could displace Wnt3a from the
membrane allowing it to be released from the cell or
inserted into lipoprotein particles.
The discovery by Takada et al. (2006) reported in this
issue ofDevelopmental Cell raises many intriguing ques-
tions. A key question is whether or not the S209 modifica-
tion is found in other Wnt proteins, also from other
species. The conservation of the serine and the sur-
rounding residues suggests that the answer will be yes.
Clarifying the role of Porcupine should be another prior-
ity. Does it play a role in both the acylation and secretion
of Wnts and are these two distinct steps? Can another
acyl-transferase partially substitute for Porcupine?
Which enzyme acylates the C77 residue? Is the failure
of the S209A mutant to be secreted because it is mis-
folded? What is the effect of mutating both the C77 and
the S209 to alanine? How should the discovery of a sec-
ond lipid modification affect the way we think of the inter-
action with recently described players in Wnt secretion:
Wls/Evi, the retromer complex, and lipoprotein parti-
cles? With respect to Wls, a recently described multi-
pass transmembrane protein dedicated to promoting the
Wnt secretion (Banziger et al., 2006; Bartscherer et al.,
2006), it will be important to determine what effect theDevelopmental Cell 11, December, 2006 ª2006 Elsevier Inc. DOI 10.1
Oncogene Addiction:
Role of Signal Attenuation
Tumors can become dependent upon signaling by
oncogenes. In a recent issue of Cancer Cell, Sharma
et al. (2006b) reported that ‘‘oncogene addiction’’acylation at Ser209 has on its interaction with Wnts. Is
this required for the association with lipoprotein parti-
cles? The answers to these questions will provide insight
into the burgeoning field of exocytosis. The answers may
also provide us with the tools/targets that we can use to
control Wnt secretion thereby treating diseases where
aberrant secretion of Wnt proteins is implicated.
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may be mediated by differential rates of signal attenu-
ation of proapoptotic and prosurvival pathways.
Human cancers often arise through a multistage pro-
cess involving gradual acquisition of numerous genetic
alterations, such as activating mutations of oncogenes
and inactivating mutations of tumor suppressor genes.
